前列腺癌诊断+.pdf

ICs 11¡£020 CO5 ÖлªÈËÃñ¹²ºÍ¹úÎÀÉúÐÐҵ±ê׼ Ws/T336¡¥ ¡ª 2011 ܳ ë¾ ÁÐÏÙ°©Õï D)iagnosis criteria For prostate Cancer 201²·o7¡¥o|·¢²¼ ÖлªÈËÃñ¹²ºÍ¹úÎÀÉú²¿ ·¢²¼ zO11-1¢²01ʵʩ Ws/T336-2011 ǰ H . ±¾±ê׼ÓÉÎÀÉú²¿ҽÁÆ·þÎñ±ê׼רҵίԱ»áÌá³ö¡£ ±¾±ê׼ÓÉÖлªÈËÃñ¹²ºÍ¹úÎÀÉú²¿Åú׼¡£ ±¾±ê׼°´ÕÕGB/T1.1-¢Ä09¸ø³öµÄ¹æÔòÆð²Ý¡£ ±¾±ê׼Æð²Ýµ¥λ:Î人´óѧÖÐÄÏҽԺ¡¢¹ã¶«ʡÈËÃñҽԺ¡¢±±¾©´óѧÃÚÄòÍâ¿ÆÑо¿Ëù¡¢±±¾©´óѧÖ×Áöҽ Ժ¡¢Ìì½òÃÚÄòÍâ¿ÆÑо¿Ëù¡¢Î÷°²½»ͨ´óѧ¸½мµÚ-ҽԺ¡¢ÉϺ£½»ͨ´óѧÈʼÃҽԺ¡¢¸´µ©´óѧ»ªɽҽԺ¡¢»ª ÖпƼ¼´óѧͬ¼ÃҽԺ¡¢µÚ¶þ¾üҽ´óѧ³¤º£ҽԺ¡¢ɽÎ÷ҽ¿Æ´óѧ¸½ÔµÚһҽԺ¡£ ±¾±ê׼Ö÷ҪÆð²ÝÈË:ÍõÐл·¡¢Áõͬ×å¡¢л´Ô»ª¡¢Íõ»³¸ì¡¢×âÀû¾ü¡¢ÄÇÑåȺ¡¢ÔÂÀûȺ¡¢ÀîÃù¡¢Ëï¹â¡¢ºØ´óÁÖ¡¢ »ÆÞÉȻ¡¢¶¡ǿ¡¢¦®¹úΰ¡¢ҶÕÂȺ¡¢ºú־ȫ¡¢ËïӱºÆ¡¢¸ßÐñ¡¢Íõ¶«ÎÄ¡£ ¢ö³§s/T336-¡¥2011 ǰÁÐÏÙ°©Õï¶Ï 1 ·¶Χ ±¾±ê׼¹æ¶¨ÁËǰÁÐÏÙ°©µÄÕï¶ÏÒÀ¾Ý¡¢Õï¶Ï¡¢¼ø±ðÕï¶Ï¡¢·ÖÆÚ¡¢½øչΣÏÕÒòËØ·ÖÎö¡£ ±¾±ê׼ÊÊÓÃÓÚȫ¹ú¸÷¼¶¸÷ÀàҽÁÆÎÀÉú»ú¹¹¼°ÆäҽÎñÈËԱ¶ÔǰÁÐÏÙ°©µÄÕï¶Ï¡£ 2 ËõÂÔÓï ÏÂÁÐËõÂÔÓïÊÊÓÃÓÚ±¾Îļþ¡£ BPH:Á¼ÐÔǰÁÐÏÙÔöÉú (benign prostatic hyperplasia) PIN:ǰÁÐÏÙÉÏƤÄÚÁö (prostatÒä intraepithelial neoplasia) DRE:ֱ³¦ָ¼ì (digital rectal examinaton) MRS:´Å¹²Õñ¹âÆ×ѧ¼ì²é (magnetÒäresonance spectroscopy) PSA:ǰÁÐÏÙÌØÒìÐÔ¿¹ԭ (prostate~specific antigen) tPSA:×ÜPSA(total PSA) fPSA:ÓÎ ÀëPSA(free PSA) PSADT:PsA±¶ Ôöʱ¼ä (PSA doubling time) TRUS:¾­ֱ³¦³¬Éù¼ì²é (transrectal ultrasonographD 3 Õï¶ÏÒÀ¾Ý 3.1 ÁÙ´²±íÏÖ ÔçÆÚǰÁÐÏÙ°©ͨ³£ûÓÐ֢״,µ«Ö×ÁöÇÖ·¸»ò×èÈûÄòµÀ¡¢°òë×¾±ʱ,Ôò»á·¢ÉúÀàËÆÏÂÄò·¹£×è»ò´Ì¼¤ ֢״,ÑÏÖØÕ߶©ÄܳöÏÖ¼±ÐÔÄòäóÁô¡¢ѪÄò¡¢Äòʧ½û¡£¹ÇתÒÆʱ¿ÉÓйÇʹ¡¢²¡ÀíÐÔ¹ÇÕÛ¡¢ƶѪ;³öÏÖ¼¹ËèѹÆÈ ¿Éµ¼ÖÂÏÂ̱֫»¾µÈ¡£ 3.2 ¸¨Öú¼ì²é 3.2¡£l ֱ³¦ָ¼ì ´ó¶àÊýǰÁÐÏÙ°©ÆðԴÓÚǰÁÐÏÙµÄÍâÖÜ´ø,DRE¶ÔǰÁÐÏÙ°©µÄÕï¶ÏºÍ·ÖÆÚ¶¼ÓÐѬҪ¼Ûֵ¡£ 3,2.2 ǰÁÐÏÙÌØÒìÐÔ¿¹ԭ¼ì²é 3.2.2.1 PsA¼ì ²âָÕ÷ ¶Ô50ËêÒÔÉÏÓÐÏÂÄò·֢״µÄÄÐÐÔ¿ÉÒÔ½øÐÐPSA¼ì²â,¶ÔÓÚÓÐǰÁÐÏÙ°©¼Ò×åʷµÄÄÐÐÔÈËȺ,¿É´Ó 45Ë꿪ʼ¶¨ÆÚ¼ì²é¡¢Ëæ·Ã¡£¶ÔDREÒì³£¡¢ÓÐÁÙ´²Õ÷Ïó (Èç ¹Çʹ¡¢¹ÇÕÛµÈ)»òӰÏñѧÒì³£µÈӦ½øÐÐPSA ¼ì²â¡£ 3.2.2.2 PsA½á ¹ûµÄÅж¨ ѪÇå×ÜPSA(tPSA)Õý ³£²Î¿¼ֵΪ0ng/mL~4.o ng/mL¡£ ѪÇåPSAÊÜÄêÁäºÍǰÁÐÏÙ´óСµÈÒòËØ l ¢ö¡äs/T336-¡¥2011 µÄӰÏì¡£ǰÁÐÏÙ°´Ħ¡¢ֱ³¦ָ¼ì¡¢°òë×¾µ¼ì²é¡¢µ¼Äò¡¢É侫¡¢ǰÁÐÏÙ´©´Ì¡¢¼±ÐÔǰÁÐÏÙÑס¢ÄòäóÁôµÈ¿ÉÄÜӰ ÏìѪÇåPSAˮƽ¡£ÓÎÀëPSA(fPSA)ºÍtPSA¿É×÷Ϊ³£¹æͬʱ¼ì²â¡£fPSA/tPsA±È ֵ¿É×